sp @11.5c is undervalued considering what is taking shape here:
* 2 X Phase 2 trials underway,
* 1 X Phase 1 trial in collaboration with the leading research organisation near completion,
* 1 X patented technology for topical applications with proven performance,
* 1 X topical antibiotic drug trial at design stage following outstanding third party generated results,
* widening recognition by the world's top leading dermatologists of Botanix' s unique pipeline set.
MC of $87m.....!??....that'd be the potential monthly revenue for just one of the drugs.
Bot Chart, page-212
-
- There are more pages in this discussion • 14,133 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
40.0¢ |
Change
0.050(14.3%) |
Mkt cap ! $724.0M | |||
| Open | High | Low | Value | Volume |
| 35.5¢ | 40.0¢ | 35.5¢ | $6.075M | 15.87M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 287187 | 39.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.0¢ | 1920397 | 33 |
View Market Depth
| Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
| BOT (ASX) Chart |